As of 2024-12-15, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (11.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.25 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -604.5%.
The range of the Relative Valuation is (8.46) - (14.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 35.0x | 25.8x |
| Forward P/E multiples | 19.2x - 33.3x | 25.7x |
| Fair Price | (8.46) - (14.66) | (11.35) |
| Upside | -476.2% - -751.4% | -604.5% |
| Date | P/E |
| 2024-12-11 | -6.11 |
| 2024-12-10 | -6.90 |
| 2024-12-09 | -8.70 |
| 2024-12-06 | -7.90 |
| 2024-12-05 | -7.58 |
| 2024-12-04 | -8.31 |
| 2024-12-03 | -7.38 |
| 2024-12-02 | -7.04 |
| 2024-11-29 | -6.36 |
| 2024-11-27 | -5.77 |
| 2024-11-26 | -5.84 |
| 2024-11-25 | -5.84 |
| 2024-11-22 | -5.72 |
| 2024-11-21 | -5.61 |
| 2024-11-20 | -5.47 |
| 2024-11-19 | -5.47 |
| 2024-11-18 | -4.88 |
| 2024-11-15 | -4.81 |
| 2024-11-14 | -4.77 |
| 2024-11-13 | -5.06 |
| 2024-11-12 | -5.52 |
| 2024-11-11 | -5.72 |
| 2024-11-08 | -5.18 |
| 2024-11-07 | -4.79 |
| 2024-11-06 | -5.02 |
| 2024-11-05 | -4.81 |
| 2024-11-04 | -4.54 |
| 2024-11-01 | -4.61 |
| 2024-10-31 | -4.63 |
| 2024-10-30 | -4.84 |
| 2024-10-29 | -4.72 |
| 2024-10-28 | -4.84 |
| 2024-10-25 | -4.77 |
| 2024-10-24 | -4.68 |
| 2024-10-23 | -4.66 |
| 2024-10-22 | -4.84 |
| 2024-10-21 | -4.68 |
| 2024-10-18 | -4.63 |
| 2024-10-17 | -4.79 |
| 2024-10-16 | -4.81 |
| 2024-10-15 | -4.84 |
| 2024-10-14 | -4.75 |
| 2024-10-11 | -4.47 |
| 2024-10-10 | -4.29 |
| 2024-10-09 | -4.38 |
| 2024-10-08 | -4.70 |
| 2024-10-07 | -4.63 |
| 2024-10-04 | -4.90 |
| 2024-10-03 | -4.45 |
| 2024-10-02 | -4.13 |